To analyze metabolic disorder-mediated regulation of MG53 activity, we established mice models with metabolic diseases by subjecting wild-type mice to a high-fat diet (HFD) for six months and evaluated the extent of their MG53 expression. This evidence concerns the gene TRIM72 and Other metabolic disease.